echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > AJKD: The humoral and cellular responses of hemodialysis patients to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccine

    AJKD: The humoral and cellular responses of hemodialysis patients to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccine

    • Last Update: 2021-10-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    In the past year, there have been multiple outbreaks of new coronary pneumonia in the hemodialysis ward .


    In the past year, there have been multiple outbreaks of new coronary pneumonia in the hemodialysis ward .


    From February 3 to April 4, 2021, 205 patients treated in three dialysis units of the Clínic Hospital in Barcelona, ​​Spain, were vaccinated.


    From February 3 to April 4, 2021, 205 patients treated in three dialysis units of the Clínic Hospital in Barcelona, ​​Spain, were vaccinated.


    The results of the study showed that among the 175 vaccinated patients who were seronegative at the baseline examination, regardless of the type of vaccine, in general, 97.


    Cells, body fluids and overall response after vaccination

    Cells, body fluids and overall response after vaccination

    In summary, although the actual clinical protection of the vaccine has not been found in this population, the overall immune response generated by the immune program in renal failure patients undergoing hemodialysis is effective


    These patients themselves have a higher risk of infection and a poor prognosis.


    Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients

    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.